Table 1.
Age, years (mean ± SD) | 67.2 ± 12.5 | |
Sex (Male), n (%) | 68 (68%) | |
ASA physical status, n (%) | II | 17 (17%) |
III | 43 (43%) | |
IV | 40 (40%) | |
Type of surgery, n (%) | Endocrinological | 1 (1%) |
Gastrointestinal | 42 (42%) | |
Gastrointestinal/Gynecological | 1 (1%) | |
Gynecological | 5 (5%) | |
Thoracic | 1 (1%) | |
Urological | 16 (16%) | |
Vascular | 32 (32%) | |
Various | 2 (2%) | |
Medication | ||
Aspirin, n (%) | No | 74 (74%) |
Yes | 26 (26%) | |
Beta blocker, n (%) | No | 64 (64%) |
Yes | 36 (36%) | |
ACEi, n (%) | No | 86 (86%) |
Yes | 14 (14%) | |
Diuretic, n (%) | No | 78 (78%) |
Yes | 22 (22%) | |
Comorbidities | ||
Ischemic heart disease, n (%) | No | 78 (78%) |
Yes | 22 (22%) | |
Arterial hypertension, n (%) | No | 36 (36%) |
Yes | 64 (64%) | |
Hypercholesterolemia, n (%) | No | 51 (51%) |
Yes | 49 (49%) | |
Diabetes, n (%) | No | 86 (86%) |
Yes | 14 (14%) | |
Stroke, n (%) | No | 93 (93%) |
Yes | 7 (7%) | |
COPD, n (%) | No | 76 (76%) |
Yes | 24 (24%) | |
Asthma, n (%) | No | 98 (98%) |
Yes | 2 (2%) | |
Other, n (%) | No | 37 (37%) |
Yes | 63 (63%) | |
suPAR (ng mL−1), mean ± SD | 8.09 ± 3.69 |
ASA, American Society of Anesthesiologists; ACEi, angiotensin-converting enzyme inhibitors; COPD, chronic obstructive pulmonary disease.